BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 26334726)

  • 1. Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration.
    Atkinson HC; Stanescu I; Frampton C; Salem II; Beasley CP; Robson R
    Clin Drug Investig; 2015 Oct; 35(10):625-32. PubMed ID: 26334726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol.
    Tanner T; Aspley S; Munn A; Thomas T
    BMC Clin Pharmacol; 2010 Jul; 10():10. PubMed ID: 20602760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects.
    Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
    Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
    J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effectiveness, pharmacokinetics, and safety of a paracetamol/ibuprofen fixed-dose combination in children undergoing adenotonsillectomy: A randomized, single-blind, parallel group trial.
    Playne R; Anderson BJ; Frampton C; Stanescu I; Atkinson HC
    Paediatr Anaesth; 2018 Dec; 28(12):1087-1095. PubMed ID: 30375109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition.
    Cheah KY; Mah KY; Pang LH; Ng SM; Wong JW; Tan SS; Tan HZ; Yuen KH
    BMC Pharmacol Toxicol; 2020 Jun; 21(1):45. PubMed ID: 32576287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
    Fortin A; Verbeeck RK; Jansen FH
    Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics and bioavailability of gemifloxacin administered as an intravenous 200 mg formulation or an oral 320 mg tablet.
    Kim MJ; Lim HS; Cho SH; Bae KS
    Clin Drug Investig; 2014 Mar; 34(3):195-201. PubMed ID: 24385283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of three ibuprofen formulations in healthy human volunteers.
    Mendes GD; Mendes FD; Domingues CC; Oliveira RA; da Silva MA; Chen LS; Ilha JO; Fernandes CE; Nucci GD
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):309-18. PubMed ID: 18541128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers.
    Stangier J; Su CA; Fraunhofer A; Tetzloff W
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1338-46. PubMed ID: 11185632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.
    Patel A; Shah T; Shah G; Jha V; Ghosh C; Desai J; Khamar B; Chakraborty BS
    Am J Cardiovasc Drugs; 2010; 10(2):95-103. PubMed ID: 20334446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.
    Liu DJ; Collaku A
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):77-86. PubMed ID: 28815997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.